5 Best Penny Stocks to Buy According to Billionaire Ken Griffin
In this article, we will take a look at the 5 best penny stocks to buy according to billionaire Ken Griffin.
Allogene Therapeutics Inc. (ALLO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 4,053,226 | $13,010,855 | -2% | 0% |
| 2. | Woodline Partners Michael Rockefeller And Karl Kroeker | 2,577,500 | $8,273,775 | -52% | 0.08% |
| 3. | Wildcat Capital Management Leonard A. Potter | 1,920,787 | $6,165,726 | 2.13% | |
| 4. | Millennium Management Israel Englander | 1,919,014 | $6,160,035 | +1443% | 0% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 1,277,700 | $4,101,417 | +31% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.60 | 190 | 819,590 | 2024-01-30 | Filing | ||
| $12.60 | 15,000 | 258,885 | 2022-01-12 | Filing | ||
| $12.60 | 155,039 | 195,039 | 2022-01-12 | Filing | ||
| $47.00 | 106,382 | 1,798,163 | 2020-06-04 | Filing | ||
| $47.00 | 40,000 | 40,000 | 2020-06-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.70 | 18,640 | 62,456 | 2023-12-18 | Filing | ||
| $4.29 | 10,000 | 25,328 | 2023-08-07 | Filing | ||
| $6.85 | 3,000 | 577,677 | 2023-02-13 | Filing | ||
| $7.04 | 3,000 | 580,677 | 2023-01-17 | Filing | ||
| $7.53 | 5,602 | 583,677 | 2022-12-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 25,241,499 | $81,025,212 | 0% | |
| 2. | 18,716,306 | $60,079,342 | 0.96% | |
| 3. | 10,001,804 | $32,105,791 | 0% | |
| 4. | 9,030,825 | $28,988,948 | 0% | |
| 5. | 6,906,761 | $22,170,703 | 0% |
News See All
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2023 Earnings Call Transcript
Operator: Thank you for standing by and welcome to Allogene Therapeutics Fourth Quarter and Full Year 2023 Conference Call. At this time, all participants are in a listen-only mode.
5 Best Rising Penny Stocks To Buy
Monopar Therapeutics (NASDAQ:MNPR) recently jumped after the company reported positive preclinical data for its MNPR-101 program.
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q3 2023 Earnings Call Transcript
Operator: Hello, and thank you for standing by. Welcome to the Allogene Therapeutics Third Quarter 2023 Conference Call.
5 Best High Risk High Reward Stocks To Buy Now
In this piece, we will take a look at the five best high risk high reward stocks to buy now.
16 Most Shorted Stocks Right Now
One of the most intriguing plays on the stock market is short selling. This is because it goes against conventional investment logic, which typically seeks to profit from an increase in share prices.
11 Best High Short Interest Stocks To Buy Now
In this piece, we will take a look at the 11 best high short interest stocks to buy now.
11 Best Biotech Penny Stocks to Buy Now
As investors begin to see light at the end of the tunnel, their risk appetite, which had vanished amid recession risks and volatility, is coming back, creating chances of major investments in high-risk...
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q2 2023 Earnings Call Transcript
Operator: Hello. Thank you for standing by, and welcome to Allogene Therapeutics Second Quarter 2023 Conference Call. After the speaker's presentation, there will be a question-and-answer session.
5 Best Short Squeeze Stocks to Buy Now
There was a surge in hedge fund ownership of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) during the third quarter of 2022, as the number of smart money shareholders of the company nearly doubled.